- Dapoxetine is the only officially approved medicine for the treatment of Premature Ejaculation.
- How much delay in ejaculation can I expect on taking Dapoxetine?
Three to eightfold delay in discharge is seen with the use of dapoxetine.
- Can I take Dapoxetine along with alcohol and with Viagra and other Viagra type of medicines (Tadalafil)?
Dapoxetine’s efficacy is unaffected by concomitant use of alcohol or Viagra and PDE 5 group of medicines.
- Is Dapoxetine better than other medicines that were used in the treatment of Premature Ejaculation?
Other medicines belonging to the SSRI group of antidepressants that were used for the treatment of PE and are still used especially where Dapoxetine is not yet officially approved, as in the United States, have to be taken daily. This increases the possibility of side effects, which include decreased erection and decreased sexual desire.
- Waldinger’s metaanalysis showed these conventional antidepressants increased IELT from two to ninefold above baseline in comparison to three to eightfold increase in Dapoxetine.
Sexual Medicine belonging to class
Selective Serotonin Reuptake Inhibitors
12. Dapoxetine: References for further reading.
Acknowledgement Source Copyright
PMID::20540653 [PubMed – indexed for MEDLINE]
2010 Jul;11(10):1741-52. doi: 10.1517/14656566.2010.493174
Australian Centre for Sexual Health, Suite 2-4, Berry Road Medical Centre, 1a Berry Road, St Leonards, NSW 2065, Australia. email@example.com
Dapoxetine: a new option in the medical management of premature ejaculation.[Ther Adv Urol. 2012]
Ther Adv Urol. 2012 Oct;4(5):233-51.
Title: Dapoxetine: a new option in the medical management of premature ejaculation.
Source Acknowledgment Thanks Dr. Anil Rathi
for powerpoint presentation through slideshare.
Department of Psychiatry
Government Medical College, Kota, Rajasthan.
Date published: August 22, 2013
Date created: August 22, 2013
Australian Centre for Sexual Health, Suite 2-4, 1a Berry Rd, St Leonards, New South Wales 2065, Australia.
Therapeutic Advances in Urology
Title: Dapoxetine: A New Option in the Medical Management of Premature Ejaculation
Chris G McMahon
Ther Adv Urol. 2012;4(5):233-251.
|Ther Adv Urol. 2012 October; 4(5): 233–251.doi: 10.1177/1756287212453866|
Copyright © The Author(s), 2012
Dapoxetine: a new option in the medical management of premature ejaculation
Chris G McMahon
Australian Centre for Sexual Health, Suite 2-4, 1a Berry Rd, St Leonards, New South Wales 2065, Australia
Conflict of interest statement: Dr Chris McMahon is an investigaror, consultant and speaker for Johnson and Johnson.
Jhanjee, A., Kumar, P., Bhatia, M. S., & Srivastava, S. (2011). Dapoxetine-A Novel Drug for Premature Ejaculation. Delhi Psychiatry Journal, 14(1), 5.
Pryor, J. L., Althof, S. E., Steidle, C., Rosen, R. C., Hellstrom, W. J. G., Shabsigh, R., . . . Kell, S. (2006). Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet, 368(9539), 929-937.
M.B.B.S., F.C.S.E.P. (International)
Accreditation: M.M.C. of India
Ex. Teaching Faculty
Seth G. S. Medical College
King Edward Memorial
K. E. M. Hospital
Grant Medical College
Sir J. J. Group of Hospitals,
University of Mumbai
Member:Indian Medical Association
Fellow: Council of Sex Education & Parenthood (International)
Sexual Health Best World Class Premier Treatment Center